Status:
COMPLETED
Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
Conditions:
Transplant
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Human herpesvirus-6 (HHV-6) and -7 (HHV-7) infections are common after transplantation. Such infections may predispose transplant patients to other infections, contribute to a recurrence of hepatitis ...
Eligibility Criteria
Inclusion
- Male or female patients who fulfill the following criteria are eligible for inclusion:
- Recipients of a liver transplant
- Able to give written informed consent
- Are willing and able to comply with the protocol
- Age \>= 18 years
Exclusion
- The following patients are not eligible for inclusion in the study:
- Patients unwilling or unable to give informed consent
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2007
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00242099
Start Date
February 1 2005
End Date
November 1 2007
Last Update
April 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G2N2